Stay updated on GABA-A Targeting in ASD Clinical Trial
Sign up to get notified when there's something new on the GABA-A Targeting in ASD Clinical Trial page.

Latest updates to the GABA-A Targeting in ASD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference5%
- Check17 days agoChange DetectedVersion bumped to v3.1.0 and several safety-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) removed; previous v3.0.2 reference removed as part of the update.SummaryDifference0.6%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and counterfeit drugs. The previous version's location details and references to autistic disorder have been removed.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to GABA-A Targeting in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GABA-A Targeting in ASD Clinical Trial page.